Evaluation of safety and tolerability of DF2156A in healthy males

• Research type

  Research Study

• Full title

  A phase 1, randomised, double-blind, placebo-controlled, multiple ascending oral dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of DF2156A in healthy male volunteers.

• Eudract number

  2009-017090-37

• Research summary

  The import did not bring in any data, please check the applicants form to see if they filled in the Research Summary. If so please import the form again. This problem may have been caused by the an application form being imported before the research summary functionality was available. Please phone the helpdesk if you have any questions.

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  09/IEC03/3

• Date of REC Opinion

  29 Mar 2010

• REC opinion

  Further Information Favourable Opinion